Jason M. Broderick | Authors


Blue Light Cystoscopy May Help to Identify Bladder Cancer Recurrence Post-BCG

December 04, 2020

“Providers should consider using BLC for surveillance of high-risk NMIBC patients undergoing BCG as it could change clinical management by identifying patients who are BCG unresponsive and eligible for alternative therapy and clinical trials,” said Meera Chappidi, MD.